Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae049 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Stephan Gaillard und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France. Hauptthemen laut MEDLINE: Craniopharyngioma, Pituitary Neoplasms, Hypothalamus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Context
Outcome of craniopharyngioma is related to its locoregional extension, which impacts resectability and the risk of surgical complications. To maximize resection and minimize complications, optic tract localization, temporal lobe extension, and hypothalamic involvement are essential factors for surgical management.
Objective
To assess the outcome of craniopharyngiomas depending on their relation to the hypothalamus location.
Methods
We conducted a retrospective analysis of 79 patients with a craniopharyngioma who underwent surgery from 2007 to 2022. Craniopharyngiomas were classified in 3 groups, depending on the type of hypothalamus involvement assessed by preoperative magnetic resonance imaging: infra-hypothalamic (type A, n = 33); perforating the hypothalamus (type B, n = 40); and supra-hypothalamic (type C, n = 6). Surgical strategy was guided by the type of hypothalamic involvement, favoring endonasal approaches for type A and type B, and transcranial approaches for type C.
Results
Long-term disease control was achieved in 33/33 (100%), 37/40 (92%), and 5/6 (83%) patients in type A, B, and C, respectively. In type B, vision was improved in 32/36 (89%) patients, while hypothalamic function was improved, stable, or worsened in 6/40 (15%), 32/40 (80%), and 2/40 (5%) patients, respectively. Papillary craniopharyngiomas were found in 5/33 (15%), 9/40 (22%), and 3/6 (50%) patients in types A, B, and C, respectively. In 4 patients, BRAF/MEK inhibitors were used, with significant tumor shrinkage in all cases.
Conclusion
Craniopharyngiomas located below the hypothalamus or perforating it can be safely treated by transsphenoidal surgery. For supra-hypothalamic craniopharyngiomas, postoperative results are less favorable, and documenting a BRAF mutation may improve outcome, if targeted therapy was efficient enough to replace surgical debulking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France.
- Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, Necker University Hospital, 75015 Paris, France.
- CNRS, INSERM, Institut Cochin, Université Paris Cité, 75014 Paris, France.
- Department of Neuropathology, Assistance Publique-Hôpitaux de Paris, La Pitié-Salpêtrière University Hospital, 75013 Paris, France.
- Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (ID 739527), Saint-Antoine Hospital, Sorbonne University, AP-HP, 75012…
- INSERM UMRS938, Saint-Antoine Research Center, Sorbonne University, 75012 Paris, France.
ORCID-Profile: Camille Vatier, Philippe Chanson, Guillaume Assié, Bertrand Baussart
Zitieren
APA
Gaillard, S., Benichi, S., Villa, C., Jouinot, A., Vatier, C., Christin-Maitre, S., Raffin-Sanson, M. L., Jacob, J., Chanson, P., Courtillot, C., Bachelot, A., Bertherat, J., Assié, G., & Baussart, B. (2024). Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae049
Vancouver
Gaillard S, Benichi S, Villa C, Jouinot A, Vatier C, Christin-Maitre S, et al. Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae049
BibTeX
@article{Gaillard2024,
author = {Gaillard, Stephan and Benichi, Sandro and Villa, Chiara and Jouinot, Anne and Vatier, Camille and Christin-Maitre, Sophie and Raffin-Sanson, Marie-Laure and Jacob, Julian and Chanson, Philippe and Courtillot, Carine and Bachelot, Anne and Bertherat, Jérôme and Assié, Guillaume and Baussart, Bertrand},
title = {Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae049}
}
EUVIMED